Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $13 | $123 |
| % Growth | – | -100% | -89.8% | – |
| Cost of Goods Sold | $1,021 | $1,039 | $2 | $206 |
| Gross Profit | -$1,021 | -$1,039 | -$1,781 | -$83 |
| % Margin | – | – | -14,245.2% | -67.8% |
| R&D Expenses | $417 | $1,234 | $1,793 | $473 |
| G&A Expenses | $1,597 | $1,644 | $1,099 | $425 |
| SG&A Expenses | $575 | $1,644 | $1,099 | $425 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1,039 | -$1,793 | $0 |
| Operating Expenses | $993 | $1,839 | $1,099 | $898 |
| Operating Income | -$2,014 | -$2,878 | -$2,880 | -$775 |
| % Margin | – | – | -23,038.4% | -631.6% |
| Other Income/Exp. Net | $79 | $84 | $181 | $14 |
| Pre-Tax Income | -$1,935 | -$2,794 | -$2,699 | -$761 |
| Tax Expense | $0 | $0 | -$987 | $32 |
| Net Income | -$1,935 | -$2,794 | -$1,712 | -$793 |
| % Margin | – | – | -13,695.1% | -646.5% |
| EPS | -0.35 | -0.52 | -0.34 | -0.13 |
| % Growth | 32.7% | -52.9% | -161.5% | – |
| EPS Diluted | -0.35 | -0.52 | -0.34 | -0.13 |
| Weighted Avg Shares Out | 6,423 | 5,882 | 5,882 | 5,882 |
| Weighted Avg Shares Out Dil | 6,459 | 5,882 | 5,882 | 5,882 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,021 | $1,039 | $409 | $41 |
| EBITDA | -$913 | -$1,755 | -$2,470 | -$734 |
| % Margin | – | – | -19,763.4% | -598.4% |